Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Researchers investigated the link between non-alcoholic fatty liver disease in individuals with type 2 diabetes mellitus (T2DM) and all-cause death and cardiovascular disease.

UpHealth Sells Cloudbreak Health Business to GTCR for $180M

What You Should Know: UpHealth, Inc. has entered into a definitive agreement to sell its wholly-owned subsidiary, Cloudbreak Health, LLC, to private equity firm GTCR

November 17, 2023

FDA backs new $82M mRNA manufacturing center at MIT

The Massachusetts Institute of Technology will be aiming to design and install a new continuous mRNA manufacturing platform, with help from the federal government. According

July 14, 2023

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain | Psychedelic Invest

SARASOTA, FL, Jan. 02, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” “we,” “us,” “our,” or the “Company”), a developmental stage biopharmaceutical company

January 2, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.